Burstein HJ, DeMichele A, Fallowfield L, Somerfield MR, et al. Endocrine and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer-Capivasertib-Fulvestrant: ASCO Rapid Recommendation Update. J Clin Oncol 2024 Mar 13:JCO2400248. doi: 10.1200/JCO.24.00248.
PMID: 38478799